BMS Expands Cardio Partnership with Avidity in Potential $2.3B Deal Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases (November 28, 2023) | By Kate Goodwin Bristol Myers Squibb is upping the ante in its partnership with Avidity Biosciences. The San Diego-based biopharma announced Tuesday an expansion of its previous collaboration with BMS,
Merck to Acquire Caraway Therapeutics, Inc. Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases (November 21, 2023) | By Merck & Co., Inc. RAHWAY, N.J., & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. announced today that the companies have
VIDEO: 11/1/2023 (November 1, 2023) | By Ross Youngs. First Meeting • In-Person and ZOOM Held on – 10/24/23 – Event Start @ 1:30PM – ET At – Meeting at Room #201 in Clapp Hall – Case Western Reserve University Address: 2080 Adelbert Rd, Cleveland, OH 44106 Sign up at Acctria.com Acctria • Neuroinflammatory Disease
